Hone Health
Hone Health is a U.S.-based direct-to-consumer telehealth clinic and longevity platform that delivers physician-guided hormone optimization and preventive care to men and women via a $65 entry biomarker test, two membership tiers ($25/mo Basic, $155/mo Premium chosen by 95% of patients), prescription medications, and integrated advanced diagnostics (Prenuvo MRI, BodySpec DEXA), serving 350,000+ tested patients.
- Company typePrivate
- Founded2020
- HeadquartersNew York, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Hone Health does
Hone Health is a U.S.-based, direct-to-consumer telehealth clinic and longevity care platform founded in 2020 by Saad Alam and headquartered in New York City. The company delivers physician-guided care across men's hormone optimization (TRT, longevity, weight loss, ED, thyroid, hair loss, heart health) and women's perimenopause/menopause (HRT, longevity, weight loss, low libido, thyroid, hair loss, heart health), serving over 350,000 tested patients and 60,000+ treated patients as of August 2025. Its core technology is a custom-built EMR with clinical decision support tools that synthesizes a 50+ biomarker blood panel, validated diagnostic questionnaires (qADAM, MENQOL, PHQ9, RIUS, FSFI), and integrated third-party diagnostics (Prenuvo whole-body MRI, BodySpec DEXA scans) into a single longitudinal care plan.
The platform is accessed via honehealth.com and a patient app, with a $65 entry-point biomarker test offered at 2,000+ CLIA-certified partner lab locations (FSA/HSA eligible, no insurance accepted). Patients convert into one of two membership tiers: Hone Basic at $25/month with semi-annual testing, or Hone Premium at $155/month (chosen by 95% of patients) with quarterly retesting, telehealth physician consults, and personalized protocols. Recurring revenue is layered with prescription medications shipped directly to the patient (e.g., Testosterone from $28/month, Sermorelin $130/month, NAD+ $165/month, Compounded Liraglutide $160/month) and a proprietary women's arousal cream. In-home IV therapy and phlebotomy were added in January 2025 via the acquisition of ivee.
Hone Health closed a $33 million Series A in January 2025 (total capital $39M; investors include Tribe Capital, PIF, Republic Capital, Vibe VC) and has since launched integrated prenatal whole-body MRI (Prenuvo, November 2025), integrated DEXA scans (BodySpec, April 2026), the Hone Heart Health cardiovascular program (June 2026), and the Menopause Time Off (MTO) Movement and Microgrant Fund (May 2026). The company is positioned as the largest men's hormone clinic in the U.S., has 11,709+ Trustpilot reviews, LegitScript certification, and an award-winning editorial platform (The Edge) anchored by a Medical Advisory & Review Board.
Hone Health firmographics
Firmographics- Name
- Hone Health
- Legal name
- Hone Health
- Website
- https://honehealth.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Hone Health is a U.S.-based direct-to-consumer telehealth clinic and longevity platform that delivers physician-guided hormone optimization and preventive care to men and women via a $65 entry biomarker test, two membership tiers ($25/mo Basic, $155/mo Premium chosen by 95% of patients), prescription medications, and integrated advanced diagnostics (Prenuvo MRI, BodySpec DEXA), serving 350,000+ tested patients.
- Ownership category
- akta.pro rank
Hone Health industry classification
Industry- Product category
- Telehealth Hormone Optimization & Longevity Care
- NAICS
- Offices of Other Health Practitioners (6213), Medical and Diagnostic Laboratories (6215)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
- akta.pro secondary industries
- Healthy Aging & Longevity Lifestyle Coaching (HSADAGAK), Chronic Disease Remote Monitoring (COPD/CHF/HTN, Weight & Symptom Tracking) (HLAHACAI)
Keywords
Where Hone Health is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Hone Health business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Supply Chain, Operations
Revenue model
- Monthly Membership Subscriptions: Recurring monthly memberships via two tiers: Hone Basic ($25/month) for testing every 6 months and member pricing on BASIC medications, and Hone Premium ($155/month) chosen by ~95% of patients, which includes testing every 3 months, physician consults, and full treatment protocols.
- One-Time Biomarker Test Sales: $65 entry-point biomarker test (50+ biomarkers) at 2,000+ partner lab locations, FSA/HSA eligible. Test can be purchased standalone or bundled with a physician consultation as a funnel into membership.
- Prescription Medication Sales: Recurring revenue from physician-prescribed medications priced per treatment (e.g., Testosterone from $28/mo, Anastrozole $22/mo, Sermorelin $130/mo, NAD+ $165/mo, Compounded Liraglutide $160/mo, Metformin $25/mo, Colchicine $37/mo, Rosuvastatin from $37/mo, Tadalafil from $25/mo) shipped directly to the patient's door plus member-exclusive supplements.
- Integrated Diagnostic Service Revenue: Revenue from integrated advanced diagnostics including Prenuvo whole-body MRI scans and BodySpec DEXA scans booked through the Hone platform, with physician-guided interpretation incorporated into the longitudinal care plan.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Hone Basic membership at $25/month with testing every 6 months |
| Subscription | Monthly | Hone Premium membership at $155/month with testing every 3 months |
| Unit Pricing | Pay-as-you-go | Initial Biomarker Test + Physician Consult at $65 (one-time) |
| Subscription | Monthly | Hone Basic initial test at $25 + $25 onboarding fee |
Go-to-market motion1 record
Distribution channels8 records
Marketing channels10 records
Hone Health product offering
Product offeringCore offering
Hone Health operates a direct-to-consumer telehealth clinic and AI-enabled longevity platform that sells monthly memberships (Hone Basic at $25/month, Hone Premium at $155/month) anchored by a $65 entry-point 50+ biomarker blood test at 2,000+ partner lab locations. Members receive private telehealth consultations with licensed physicians, personalized treatment protocols, prescription medications shipped directly to their door, and access to integrated advanced diagnostics including Prenuvo whole-body MRI and BodySpec DEXA scans for both men (TRT, longevity, weight loss, ED, thyroid, hair loss) and women (menopause HRT, longevity, weight loss, low libido, thyroid, hair loss).
Product overview
Hone Health operates as a unified telehealth and longevity care platform anchored by two membership tiers — Hone Basic ($25/month) and Hone Premium ($155/month) — built around a core Optimal Health Biomarker Test ($65) that analyzes 50+ biomarkers across blood, electrolytes, heart, hormones, immunity, kidneys, liver, metabolic health, and thyroid systems. The platform delivers specialty care modules for men (TRT, longevity, weight loss, ED, thyroid, hair loss, and heart health) and women (menopause HRT, longevity, weight loss, low libido, thyroid, hair loss, and heart health), supported by physician-led telehealth consultations and an in-home healthcare service acquired through ivee. Recent expansions include the Hone Heart Health cardiovascular program, the Menopause Time Off (MTO) Movement, and integrated third-party diagnostics through partnerships with BodySpec (DEXA scans) and Prenuvo (whole-body MRI). All of this is underpinned by The Edge content platform and the company's positioning as an AI-enabled, physician-guided longevity platform serving over 200,000 patients.
Differentiator
Problem solved
Functional benefit
Brands
- Hone Heart Health: Cardiovascular care program launched in June 2026 designed to identify heart disease risk early using multi-system analysis with a 50+ biomarker blood panel.
Products and services
- Hone Health Telehealth Platform Online telehealth clinic and AI-enabled personalized longevity care platform for men and women that combines advanced biomarker testing, physician-led consultations, prescription medications, and integrated advanced diagnostics into longitudinal care plans addressing hormones, metabolism, cardiovascular health, thyroid, sexual health, weight, and aging.
- Optimal Health Biomarker Test
Quantifiable outcome
- 95% of patients choose Hone Premium ($155/month) membership
- +6 more outcomes
Companies that use Hone Health
Customer profileNamed customers16 records
Segments4 records
Ideal customer profiles4 records
Hone Health technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability4 records
Feature6 records
Hone Health partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered minor, flagship and core.
- PvolveminorPvolve is named as a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- WthnminorWthn is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- mywowfitminormywowfit is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- Tone HouseminorTone House is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- WomanessminorWomaness is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- Higher DoseminorHigher Dose is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- Barre 3minorBarre 3 is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- Genova DiagnosticsminorGenova Diagnostics is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- Mission FitminorMission Fit is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- WishiminorWishi is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- NueminorNue is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- Hit HouseminorHit House is a partner supporter of the Menopause Time Off (MTO) Movement, displayed alongside other partner logos on the MTO microsite.
- BodySpecflagshipHone Health integrated BodySpec's clinical-grade DEXA body composition scans into its personalized longevity care platform in April 2026. The integration provides detailed diagnostics on body fat, muscle mass, bone density, and metabolic health, and shifts preventive bone density screening earlier than the traditional age 65 threshold.
- Ashley CamerinicoreAshley Camerini joined Hone Health as Senior Vice President of Strategic Growth Initiatives in February 2026. Previously CEO of Rumble Boxing (acquired by Xponential Fitness), with senior leadership roles at Barry's and investment banking roles at Jefferies and L Catterton. Role is newly created to scale new growth opportunities, forge strategic partnerships, and expand reach in the longevity care sector.
- PrenuvoflagshipHone Health integrated Prenuvo's whole-body MRI scans into its longevity care platform in November 2025. Patients can book Prenuvo scans through the Hone Health app, receive detailed radiologist-reviewed reports, and work with Hone clinicians on personalized treatment plans. Prenuvo has completed over 150,000 scans; 1 in 20 detects a potentially life-saving diagnosis.
- iveecoreHone Health acquired ivee in January 2025 alongside its $33M Series A funding. ivee is an at-home healthcare services platform offering at-home IV therapy and phlebotomy. The acquisition extends Hone's offerings into in-home healthcare services as part of its longevity care expansion.
- Broad HealthflagshipBroad Health is the affiliated medical practice through which Hone works to find physicians. Through this partnership, Hone is building a network of hormone optimization, preventative, and regenerative physicians. The independent, physician-owned medical group is responsible for all decisions related to physicians and medical care.
- Paul WesleycoreActor, entrepreneur, and investor Paul Wesley serves as a Hone Health brand ambassador, featured prominently on the homepage with a personal quote about partnering with Hone on the longevity pursuit.
- Nikki and Brie GarciacoreAthletes, podcast hosts and mothers Nikki and Brie Garcia serve as Hone Health brand ambassadors, featured on the homepage sharing their experience using Hone's biomarker testing.
- Dan ChurchillcoreChef, hybrid athlete, and entrepreneur Dan Churchill serves as a Hone Health brand ambassador, sharing how Hone helped him understand his endocrine system.
- Louisa NicolacoreNeurophysiologist, podcast host, and scientist Louisa Nicola serves as a Hone Health brand ambassador, featured for her testosterone optimization success (11 to 25 ng/dL after 3 months on Hone).
- Brendan FalliscoreInternational DJ, entrepreneur, and father Brendan Fallis serves as a Hone Health brand ambassador, featured in a dedicated Edge article 'Brendan Fallis Turned Data into Power.'
Scale indicators9 records
Recent moves8 records
Expansion highlights6 records
Hone Health competitors and assessment
Company assessmentDirect peers
- Hims & Hers Health: Public D2C telehealth company offering men's and women's health treatments (TRT, ED, hair loss, weight loss, mental health) via subscription. Most directly comparable to Hone in business model, customer base, and category.
- Ro: D2C telehealth platform spanning men's health (Roman), women's health, weight loss (Ro Body), and diagnostics. Direct competitor in men's hormone care with a similarly integrated vertical model.
- Function Health: Membership-based preventive health platform offering 100+ biomarker testing and physician-led interpretation, targeting the same 'longevity' consumer and competing head-to-head for the same demographic as Hone.
- InsideTracker: Blood-based biomarker analysis with personalized healthspan/longevity recommendations. Comparable to Hone's 50+ biomarker test + protocol offering, though without the in-house physician prescribing layer.
- Midi Health: Telehealth clinic focused on perimenopause and menopause care for women, with insurance coverage. Direct competitor to Hone's women's menopause and HRT offering.
- Calibrate: Telehealth weight loss program combining GLP-1 medications with coaching. Comparable in structure to Hone's weight loss program (Sermorelin, Liraglutide, Phentermine) and shares the D2C subscription model.
Broad incumbents
- Maven Clinic: Larger virtual care provider for women and families, with strong employer channel. Overlaps with Hone's women's health and menopause modules, but its core is maternity/fertility rather than hormone optimization.
Emerging players
- Evernow: Telehealth provider focused exclusively on perimenopause and menopause care for women. Narrower than Hone's women's offering but directly competes for the same patient demographic.
- LetsGetChecked: At-home diagnostics and telehealth platform offering direct-to-consumer lab tests and physician follow-up. Adjacent competitor in the D2C testing and integrated care space.
- Veri: Continuous glucose monitor and metabolic-health program focused on optimizing energy and body composition. Competes for the same healthspan/longevity-oriented customer segment as Hone.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Hone Health social profiles
Digital presenceHone Health compliance and trust
Trust signalCompliance3 records
Hone Health financial estimates
Financial estimateRevenue estimate
Valuation estimate
Hone Health leadership team
Management profileNumber of profiles
Profiles9 records
Hone Health subsidiaries and ownership
Company hierarchySubsidiaries1 record
Hone Health funding detail
Funding detailFunding overview
Funding rounds4 records
Investors16 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Hone Health M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Hone Health
What does Hone Health do?
Hone Health operates a direct-to-consumer telehealth clinic and AI-enabled longevity platform that sells monthly memberships (Hone Basic at $25/month, Hone Premium at $155/month) anchored by a $65 entry-point 50+ biomarker blood test at 2,000+ partner lab locations. Members receive private telehealth consultations with licensed physicians, personalized treatment protocols, prescription medications shipped directly to their door, and access to integrated advanced diagnostics including Prenuvo whole-body MRI and BodySpec DEXA scans for both men (TRT, longevity, weight loss, ED, thyroid, hair loss) and women (menopause HRT, longevity, weight loss, low libido, thyroid, hair loss).
Is Hone Health a public or private company?
Hone Health is a private company. It is classified as venture growth investor backed and is currently operating.
When was Hone Health founded?
Hone Health was founded in 2020. It employs 11 to 50 people.
Where is Hone Health based?
Hone Health is headquartered in New York, United States, in the North America region.
How does Hone Health make money?
Four revenue lines are on record. Monthly Membership Subscriptions are the primary driver. The others are one-Time Biomarker Test Sales, prescription Medication Sales and integrated Diagnostic Service Revenue.
Who are Hone Health's main competitors?
Direct peers on record are Hims & Hers Health, Ro, Function Health, InsideTracker, Midi Health and Calibrate. Maven Clinic is listed as a broad incumbent. Emerging players are Evernow, LetsGetChecked and Veri.
Does Hone Health have an API?
No public API is recorded for Hone Health.
What industry is Hone Health in?
Hone Health's product category is Telehealth Hormone Optimization & Longevity Care. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HSADAGAK, Healthy Aging & Longevity Lifestyle Coaching. Its NAICS code is 6213 and its SIC code is 8011.